Renaissance Technologies - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 131 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,152
-65.2%
663,000
-56.7%
0.01%
-57.1%
Q2 2023$14,814
-14.7%
1,530,400
-3.4%
0.02%
-8.7%
Q1 2023$17,363
+143.1%
1,584,200
-4.2%
0.02%
+130.0%
Q4 2022$7,142
-99.9%
1,653,200
+125.3%
0.01%
+25.0%
Q3 2022$5,518,000
-8.3%
733,800
+22.6%
0.01%
+14.3%
Q2 2022$6,016,000
-71.3%
598,600
-64.7%
0.01%
-72.0%
Q1 2022$20,974,000
+96.3%
1,694,200
+262.7%
0.02%
+92.3%
Q4 2021$10,682,000
+202.9%
467,071
+95.1%
0.01%
+225.0%
Q3 2020$3,526,000
-81.2%
239,400
-79.3%
0.00%
-75.0%
Q2 2020$18,804,000
-9.9%
1,157,500
-19.6%
0.02%
-20.0%
Q1 2020$20,875,000
+78.1%
1,438,800
+148.7%
0.02%
+122.2%
Q4 2019$11,721,000
+20463.2%
578,534
+5284.2%
0.01%
Q3 2019$57,000
-87.4%
10,745
-84.3%
0.00%
Q2 2019$452,000
-61.3%
68,623
-61.8%
0.00%
-100.0%
Q1 2019$1,168,000
+382.6%
179,700
+239.1%
0.00%
Q4 2017$242,000
-33.9%
53,001
-9.1%
0.00%
Q3 2017$366,000
-15.9%
58,301
-17.9%
0.00%
-100.0%
Q2 2017$435,000
-43.9%
71,001
-32.8%
0.00%0.0%
Q1 2017$776,000
+203.1%
105,700
+24.2%
0.00%
Q3 2016$256,000
+124.6%
85,100
+107.1%
0.00%
Q2 2016$114,000
+29.5%
41,100
+35.2%
0.00%
Q1 2016$88,000
-4.3%
30,400
-18.3%
0.00%
Q4 2015$92,00037,2000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,040,530$8,074,5132.72%
NEA Management Company, LLC 3,969,834$30,845,6102.38%
TANG CAPITAL MANAGEMENT LLC 750,000$5,827,5000.82%
ARMISTICE CAPITAL, LLC 6,048,000$46,992,9600.72%
IRONWOOD INVESTMENT MANAGEMENT LLC 95,990$745,8420.46%
Antara Capital LP 639,700$4,970,4690.44%
HighMark Wealth Management LLC 59,999$466,1920.39%
Artal Group S.A. 1,000,000$7,7700.33%
Jackson Creek Investment Advisors LLC 97,513$7580.32%
AlphaCentric Advisors LLC 50,000$388,5000.22%
View complete list of AURINIA PHARMACEUTICALS INC shareholders